Navigation Links
Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
Date:10/18/2007

CARLSBAD, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that it has added a new diabetes drug targeting the sodium dependent glucose transporter type 2 (SGLT2) to its development pipeline. ISIS 388626, a generation 2.2 antisense drug that acts in the kidney to increase glucose excretion, complements Isis' existing pipeline of drugs in development for the treatment of diabetes, each of which act upon targets in the liver through distinct mechanisms to improve insulin sensitivity, reduce glucose production, or affect other metabolic aspects of this complex disease.

The productivity of antisense technology has allowed Isis to rapidly evaluate many potential targets for treatment of complex metabolic diseases such as diabetes and obesity in well established animal models. To date, Isis has analyzed the effects of inhibiting over 120 distinct gene targets in animals, and the efficiency of the drug discovery process should continue to provide a rich source of promising drugs with which to populate Isis' future pipeline. ISIS 388626 is the fourth development candidate to come out of Isis' extensive metabolic disease drug discovery program.

"We think ISIS 388626 is an exciting addition to our portfolio that offers a kidney-based mechanism, which will complement our other diabetes drugs in development," said Sanjay Bhanot, M.D., Ph.D., Vice President of Metabolic Diseases Research & Development, Isis Pharmaceuticals. "This is the first kidney target that we have approached with our second-generation drugs, and we are quite encouraged by what we have seen in the animal models. We know that antisense drugs distribute most readily to the liver, kidney, fat cells, b
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Cancer drugs in development nearly doubled since 1995
3. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
4. Role of zinc in development
5. Particulate matter affects lung development
6. Fossil teeth and human development
7. High development costs hinder entry of cancer super drugs into the market
8. Fireflies help speed development of new drugs
9. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
10. New fertility drug development techniques by Organon
11. Biosensor chip to help drug development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 ... 2010 DePuy hip recall continue to move forward in ... According to documents filed in California’s San Francisco Superior ... seeking an expedited trial of her DePuy hip lawsuit ... v. DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Western University ... its status of “Full Accreditation” for the next seven ... on Education (COE). , “This is a magnificent achievement, ... hard work and student outcomes,” said College of Veterinary ... express my appreciation to the faculty, staff, preceptors, and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... E-Dentists.com has announced the launch of ... Media Surge, a leading medical Internet marketing agency. ... service will focus on providing dentists the help they ... their competitive keywords. The dental SEO analysis covers a ... on what their competitors are doing right. The goal ...
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
Breaking Medicine News(10 mins):Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2
... into the gut, according to a study published this ... There are several drugs that would have more ... absorption by the lower intestine. However, in order to ... medication delivered by mouth must surmount several barriers including ...
... By Randy Dotinga HealthDay Reporter , THURSDAY, ... and older white Americans are sicker than their counterparts in ... long as the Brits, thanks to doctors and drugs. ... care from the health-care system," explained study co-author James P. ...
... biceps (LHB) tendinopathy, which is a pain and/or tearing ... and/or a rotator cuff tear. LHB tendinopahy can be ... Because of the variety of the causes and the ... examination, including radiographic imaging to determine the diagnosis and ...
... a safe, effective way of removing bowel tumours and ... colorectal cancer, according to researchers from the University of ... time in hospital and recover more quickly from the ... way of doing surgery does not make patients with ...
... that multiple antiepileptic drugs (AEDs) used by pregnant women ... their teenagers. The research team from Karolinska University Hospital ... exposure to AEDs in utero may have a negative ... Epilepsia , a journal published by Wiley-Blackwell on ...
... , WEDNESDAY, Nov. 3 (HealthDay News) -- Higher levels ... care for Medicare patients, a new study has found. ... and Information Set revealed wide variation across the United ... of inappropriate prescriptions for the elderly, said the researchers ...
Cached Medicine News:Health News:Colonic navigation 2Health News:Older Americans Sicker Than British Peers... 2Health News:5-year results show keyhole bowel cancer surgery is safe and effective 2Health News:Teens of epileptic moms display poor school performance 2Health News:Pricey Drugs May Not Mean Better Care 2
(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de ... ), un destacado desarrollador y fabricante de herramientas ... la diagnosis y tratamiento de la enfermedad vascular ... del ensayo ADVISE ( Ad enosine V ... E valuation) II durante la sesión de ensayo ...
(Date:5/23/2013)... , May 23, 2013 Amgen (NASDAQ: ... th Annual  Healthcare Conference on Thursday, May 30, 2013, ... , beginning at 9:20 a.m. Eastern Daylight Time. ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... Md., Dec. 21, 2011 The U.S. Food and Drug ... Flex Massager, imported by King International and sold by ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) The Shoulder Flex Massager is ... over the Internet. It is intended to provide users with ...
... NEW YORK, Dec. 21, 2011   Delcath Systems, Inc. ... to the Company,s Medical Advisory Board. ... the International Liver Cancer Association (ILCA), Dr. Gores will ... drug induced liver pathology to our Medical Advisory Board," ...
Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 2Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 3Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: